Contraindications to bivalent HPV vaccination include contraindications for those who are allergic to the components of the vaccine, and precautions include the possibility of syncopal reactions, postponement of vaccination when suffering from febrile illnesses, suspension or postponement of vaccination for pregnant and breastfeeding women, and inability to prevent lesions in which HPV infection has already occurred.
The bivalent HPV vaccine, also known as the bivalent human papillomavirus adsorbed vaccine, is a shot that prevents HPV 16 and HPV 18 viral infections, and is intended for women between the ages of 9 and 45. Those who are allergic to any of the components or excipients in the vaccine are not suitable for bivalent HPV vaccination, and the vaccination may cause complications such as fever and allergy.
Some patients may experience syncope after bivalent HPV vaccination, resulting in falls and injuries. For people with fever or acute attack of serious diseases, vaccination should be prohibited or postponed until the condition is stabilized or cured.
Bivalent HPV vaccination is not recommended for women during pregnancy, and should be delayed for women who are planning to become pregnant or are already pregnant. Women who are breastfeeding should be cautious about receiving the bivalent HPV vaccine, which may be metabolized by breast milk and produce unfavorable conditions for the infant.
The bivalent HPV vaccine is for preventive use only and is not indicated for the treatment of HPV-associated lesions that have already occurred, nor does it prevent the progression of the lesions.
It is recommended to stay on-site for at least 30 minutes after vaccination with bivalent HPV vaccine as required by the vaccination protocol. If symptoms such as itchy skin, redness, swelling, and difficulty breathing occur after receiving bivalent HPV vaccine, you should go to a regular hospital in time.